Logo

Geospiza Closes $3M in Financing

Dec 04, 2006
NEW YORK (GenomeWeb News) - Geospiza today said it has completed a $3 million round of series A stock financing.
 
Geospiza, which sells genomic data-management software, said it intends to use the funds to add product and sales staff to meet increasing demand.
 
The company said it will also use the funds to expand a collaboration with Applied Biosystems that the companies began in 2005 and expanded in August.
 
Geospiza said that the development of new tests for cancer and infectious disease is driving demand for its software, and that its customers are seeing increased pressure to "streamline their analytical procedures and reduce testing backlog."

Filed under

Informatics
Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.